Search results
Results from the WOW.Com Content Network
For example, the last time the 10-year climbed near 5% in the fall of 2023, the S&P 500 fell for three straight months, with the benchmark index declining as much as 10% over the period.
In May 2019, Tonix reported in-licensing the Phase 2 asset, TNX-1300 (T172R/G173Q double-mutant cocaine esterase 200 mg, i.v. solution), for the treatment of cocaine intoxication. [58] [59] TNX-1300 (formerly known as RBP-8000) is being developed under an Investigational New Drug application (IND) for the treatment of cocaine intoxication. [60]
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
US stocks have been slumping heading into the first full-on week of 2025.. In the past five trading sessions, the S&P 500 is down more than 1.5%, while the Nasdaq Composite is off nearly 2% ...
Tianeptine/naloxone (developmental code names TNX-601, TNX-601-CR, TNX-601-ER), or naloxone/tianeptine, is an extended-release combination of tianeptine, an atypical μ-opioid receptor agonist, and naloxone, an orally inactive μ-opioid receptor antagonist, which was under development for the treatment of major depressive disorder, post-traumatic stress disorder (PTSD), and neurocognitive ...
Talizumab (TNX-901) is a humanized monoclonal antibody that was under development by Tanox in Houston, Texas as a new-concept therapeutic for allergic diseases. The unique anti-IgE antibody was designed to target immunoglobulin E and IgE-expressing B lymphocytes specifically, without binding to IgE already bound by the high affinity IgE receptors on mast cells and basophils.
Economists had expected the index to tick down to 54.3. Chris Williamson, chief business economist at S&P Global Market Intelligence, said the data shows the US economy's growth is chugging along ...
A video news release (VNR) is a video segment made to look like a news report, but is instead created by a PR firm, advertising agency, marketing firm, corporation, government agency, or non-profit organization.